Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$108.81 - $179.33 $666,678 - $1.1 Million
-6,127 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$119.61 - $157.85 $8,851 - $11,680
74 Added 1.22%
6,127 $890,000
Q4 2021

Feb 10, 2022

BUY
$142.57 - $190.86 $5,132 - $6,870
36 Added 0.6%
6,053 $937,000
Q3 2021

Nov 12, 2021

SELL
$142.45 - $169.82 $15,669 - $18,680
-110 Reduced 1.8%
6,017 $1.03 Million
Q2 2021

Aug 11, 2021

BUY
$135.08 - $161.1 $333,107 - $397,272
2,466 Added 67.36%
6,127 $957,000
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $10,175 - $14,119
74 Added 2.06%
3,661 $518,000
Q4 2020

Feb 11, 2021

BUY
$164.63 - $211.93 $590,527 - $760,192
3,587 New
3,587 $621,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Opseu Pension Plan Trust Fund Portfolio

Follow Opseu Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.